Recurrence and progression in non-muscle-invasive bladder cancer using EORTC risk tables

It was the aim of this study to evaluate the recurrence and progression at 1, 3 and 5 years in patients with non-muscle-invasive bladder cancer (NMIBC) who underwent a transurethral resection of bladder cancer following intravesical adjuvant chemotherapy or immunotherapy if indicated and to compare...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Urologia internationalis Ročník 89; číslo 1; s. 61
Hlavní autori:	Altieri, Vincenzo Maria, Castellucci, Roberto, Palumbo, Pietro, Verratti, Vittore, Sut, Michal, Olivieri, Raffaella, Manco, Rossella, Ricciardulli, Stefano, Nicolai, Michele, Criniti, Pasquale, Tenaglia, Raffaele Lanfranco
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland 01.01.2012
Predmet:	Adult Aged Aged, 80 and over Chemotherapy, Adjuvant Chi-Square Distribution Cystectomy - adverse effects Disease Progression Female Humans Immunotherapy Italy Male Middle Aged Multivariate Analysis Neoplasm Grading Neoplasm Invasiveness Neoplasm Recurrence, Local Neoplasm Staging Neoplasms, Multiple Primary Risk Assessment Risk Factors Time Factors Treatment Outcome Tumor Burden Urinary Bladder Neoplasms - immunology Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - surgery Italy
ISSN:	1423-0399, 1423-0399
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!